Literature DB >> 25616573

Evidence for idiotype-directed immunosurveillance is restricted to follicular lymphoma and attributable to somatic hypermutation.

Dimitrios Papaioannou1, Anna-Maria Strothmeyer1, Marcus Dühren-von Minden1, Andrea Keppler-Hafkemeyer1, Katja Zirlik1, Kristina Mikesch1, Cornelis A M van Bergen2, Marcelo A Navarrete3, Hendrik Veelken4.   

Abstract

Entities:  

Keywords:  B-cell lymphoma; BCR-directed immunosurveillance; follicular lymphoma; somatic hypermutation

Mesh：

Substances：

Year:  2015        PMID： 25616573      PMCID： PMC4380737          DOI： 10.3324/haematol.2014.111252

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load.

Authors:  W M Aarts; R J Bende; E J Steenbergen; P M Kluin; E C Ooms; S T Pals; C J van Noesel
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

2.  Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies.

Authors:  A Trojan; J L Schultze; M Witzens; R H Vonderheide; M Ladetto; J W Donovan; J G Gribben
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

3.  Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma.

Authors:  Marcelo A Navarrete; Kristina Heining-Mikesch; Frank Schüler; Cristina Bertinetti-Lapatki; Gabriele Ihorst; Andrea Keppler-Hafkemeyer; Gottfried Dölken; Hendrik Veelken
Journal:  Blood       Date:  2010-11-02       Impact factor: 22.113

4.  Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli.

Authors:  Cristina Bertinetti; Frederic Simon; Katja Zirlik; Kristina Heining-Mikesch; Dietmar Pfeifer; Frank Osterroth; Felicia M Rosenthal; Hendrik Veelken
Journal:  Eur J Haematol       Date:  2006-07-27       Impact factor: 2.997

5.  Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma.

Authors:  M L Cleary; T C Meeker; S Levy; E Lee; M Trela; J Sklar; R Levy
Journal:  Cell       Date:  1986-01-17       Impact factor: 41.582

6.  Stimulation of cytotoxic T cells against idiotype immunoglobulin of malignant lymphoma with protein-pulsed or idiotype-transduced dendritic cells.

Authors:  F Osterroth; A Garbe; P Fisch; H Veelken
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

7.  Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression.

Authors:  Cristina Bertinetti; Katja Zirlik; Kristina Heining-Mikesch; Gabriele Ihorst; Heide Dierbach; Cornelius F Waller; Hendrik Veelken
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

8.  Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype.

Authors:  Laura A Smit; Richard J Bende; Jan Aten; Jeroen E J Guikema; Wilhelmina M Aarts; Carel J M van Noesel
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

9.  Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas.

Authors:  Jobst Greeve; Antje Philipsen; Kristina Krause; Wolfram Klapper; Klaus Heidorn; Brian E Castle; Joe Janda; Kenneth B Marcu; Reza Parwaresch
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113

10.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.

Authors:  Sandeep S Dave; George Wright; Bruce Tan; Andreas Rosenwald; Randy D Gascoyne; Wing C Chan; Richard I Fisher; Rita M Braziel; Lisa M Rimsza; Thomas M Grogan; Thomas P Miller; Michael LeBlanc; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Joseph M Connors; Peter M Lansdorp; Qin Ouyang; T Andrew Lister; Andrew J Davies; Andrew J Norton; H Konrad Muller-Hermelink; German Ott; Elias Campo; Emilio Montserrat; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Liming Yang; John Powell; Hong Zhao; Neta Goldschmidt; Michael Chiorazzi; Louis M Staudt
Journal:  N Engl J Med       Date:  2004-11-18       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.